Prevalence and Risk Factors of Microvascular Complications in Patients with Type 2 Diabetes Mellitus Attending a Tertiary Care Centre

  • Yogesh Dhabarde Department Of General Medicine,Shri Balaji medical institute of Medical Science, Raipur, Chhattisgarh, India
  • Prafull Kumar Kurrey Department Of General Medicine, Raipur Institute Of Medical Science, Raipur, Chhattisgarh, India
DOI: https://doi.org/10.61280/tjpls.v13i2.262

Keywords:

Type 2 diabetes mellitus, Microvascular complications, Retinopathy, Nephropathy, Neuropathy, Risk factors, Prevalence

Abstract

Background: Microvascular complications such as diabetic retinopathy, nephropathy, and neuropathy are major causes of morbidity in patients with type 2 diabetes mellitus (T2DM). Their early detection and identification of associated risk factors are crucial for preventing progression.
Objectives: To determine the prevalence and risk factors of microvascular complications among patients with T2DM attending a tertiary care center.
Methods: A cross-sectional observational study was conducted among 300 patients with T2DM attending a tertiary care hospital. Clinical, biochemical, and anthropometric parameters were recorded. Screening for diabetic retinopathy, nephropathy, and neuropathy was performed using standard methods. Associations between complications and risk factors were analyzed using logistic regression.
Results: The overall prevalence of any microvascular complication was 38.3%. Diabetic neuropathy (24.7%) was the most common, followed by nephropathy (21.3%) and retinopathy (18.0%). Increasing age (>50 years), duration of diabetes (>10 years), poor glycemic control (HbA1c ≥8%), hypertension, dyslipidemia, and obesity were independently associated with microvascular complications (p<0.05).
Conclusion: Microvascular complications were highly prevalent among T2DM patients attending tertiary care. Age, duration of diabetes, poor glycemic control, and comorbidities were major predictors. Regular screening and optimal metabolic control are essential to reduce disease burden.

Downloads

Download data is not yet available.

Author Biographies

Yogesh Dhabarde , Department Of General Medicine,Shri Balaji medical institute of Medical Science, Raipur, Chhattisgarh, India

Assistant Professor

Prafull Kumar Kurrey, Department Of General Medicine, Raipur Institute Of Medical Science, Raipur, Chhattisgarh, India

Assistant Professor

References

International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: IDF; 2023.

Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77-82.

Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India. Ophthalmology. 2012;119(2):301-7.

Ramachandran A, Snehalatha C, Satyavani K, et al. Prevalence of vascular complications in type 2 diabetes. J Assoc Physicians India. 1999;47:1152-6.

Akter S, Rahman MM, Abe SK, Sultana P. Risk factors for diabetic complications. Diabetol Metab Syndr. 2014;6:109.

Discover MEA Study Investigators. Microvascular complications in T2DM cohort. J Diabetes Complications. 2022;36(4):108123.

Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with complications. BMJ. 2000;321:405-12.

Adler AI, Stratton IM, Neil HA, et al. Association of systolic BP with complications. BMJ. 2000;321:412-9.

American Diabetes Association. Standards of medical care in diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1-350.

Klein R, Klein BEK. Epidemiology of diabetic retinopathy. Ophthalmology. 1995;102:7-16.

Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies consensus. Diabetes Care. 2010;33:2285-93.

Mogensen CE. Diabetic nephropathy: pathogenesis. Kidney Int. 1983;24:673-9.

Vinik AI, Nevoret ML, Casellini C. Diabetic neuropathy risk factors. Endocrinol Metab Clin North Am. 2013;42:747-87.

Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence of diabetic retinopathy. Diabetes Care. 2012;35:556-64.

Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease in diabetes. J Am Soc Nephrol. 2013;24:302-8.

Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-36.

Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies. Diabetes Care. 2005;28:956-62.

Zoungas S, Woodward M, Li Q, et al. Impact of age and duration. Diabetologia. 2014;57:2465-74.

Crawley S, et al. Metabolic syndrome and complications. Diabetes Care. 2006;29:1880-5.

UK Prospective Diabetes Study Group. Intensive glucose control. Lancet. 1998;352:837-53.

Tesfaye S, Selvarajah D. Advances in diabetic neuropathy. Nat Rev Endocrinol. 2012;8:537-47.

Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of diabetic nephropathy. Nat Rev Nephrol. 2016;12:73-81.

Statistics
64 Views | 0 Downloads
Dimension Citations

Published

30-04-2026

How to Cite

Yogesh Dhabarde, and Prafull Kumar Kurrey. “Prevalence and Risk Factors of Microvascular Complications in Patients With Type 2 Diabetes Mellitus Attending a Tertiary Care Centre”. Tropical Journal of Pharmaceutical and Life Sciences, vol. 13, no. 2, Apr. 2026, pp. 46-51, doi:10.61280/tjpls.v13i2.262.

Issue

Section

Research Article